As the worldwide population ages, oncologists are often required to make difficult and
complex decisions regarding the treatment of older people (aged 65 years and older) with …

Aging is the inevitable time-dependent decline in physiological organ function and is a
major risk factor for cancer development. Due to advances in health care, hygiene control …

Adults aged 85 years and older, the “oldest old,” are the fastest‐growing age group in the
United States, yet relatively little is known about their cancer burden. Combining data from …

Cellular senescence occurs in proliferating cells as a consequence of various triggers
including telomere shortening, DNA damage, and inappropriate expression of oncogenes …

Although the prevalence of malnutrition in the old age is increasing worldwide a synthetic
understanding of the impact of aging on the intake, digestion, and absorption of nutrients is …

Age is closely related with the occurrence and development of tumors, and with treatment
outcomes. To improve the accuracy and rigor of preclinical studies, and to enhance …

Aging is a complex process. It is considered a risk factor for several diseases such as
cancer, neurodegenerative diseases, cardiovascular diseases, and diabetes, most of which …

At their proliferative limit, normal cells arrest and undergo replicative senescence, displaying
large cell size, flat morphology, and senescence-associated beta-galactosidase (SA-β-Gal) …

Epigallocatechin gallate (EGCG) is the main bioactive component of catechins
predominantly present in various types of tea. EGCG is well known for a wide spectrum of …

Over the past few decades, cellular senescence has been identified in cancer patients
undergoing chemotherapy and radiotherapy. Senescent cells are generally characterized by …